SEC Form 4 · accession 0001493152-17-002428
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allen Wolff
Officer — CFO and EVP
Period of report
Mar 13, 2017
Accepted (ET)
Mar 14, 2017 · 9:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 13, 2017 | A | 7,506 | $0.00 | A | 35,716 | D | |
| Common StockF2 | holding | — | — | — | 2,100 | I | Seefootnote | |
| Common StockF3 | holding | — | — | — | 2,100 | I | Seefootnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares issued in lieu of a cash payout of the incentive compensation earned by the reporting person under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan and pursuant to the NTN Buzztime, Inc. Executive Incentive Plan for Eligible Employees of NTN Buzztime, Inc. Fiscal Year 2016, as amended (the 2016 EIP). Under the 2016 EIP, the decision to pay the incentive compensation earned in shares instead of in cash is made by the Nominating and Corporate Governance/Compensation Committee of the Board of Directors of the issuer at its discretion and in its sole determination.
- F2As custodian of Minor Child 1.
- F3As custodian of Minor Child 2.